Journal of Biological Chemistry · 2013 · 86 citations · 35 references
Life SciencesMolecular BiologyOncologyMolecular OncologyOncogenesSignal TransductionCancer MetabolismCellular RespirationEnergy MetabolismGlycolysis RegulationMetabolic Reprogramming In CancerOncogenic Signaling PathwaysBiochemical CharacterizationMitochondrial Respiration ControlPhosphorylation-dependent ActivationPhosphorylation-dependent RegulationTherapeutic Target IdentificationTumor Cell MetabolismTumor MetabolismWarburg Effect
Pyruvate kinase M2 (PKM2) is a key player in the Warburg effect of cancer cells. However, the mechanisms of regulating PKM2 are not fully elucidated. Here, we identified the protein-serine/threonine kinase PIM2, a known oncogene, as a novel binding partner of PKM2. The interaction between PIM2 and PKM2 was confirmed by multiple biochemical approaches in vitro and in cultured cells. Importantly, we found that PIM2 could directly phosphorylate PKM2 on the Thr-454 residue, resulting in an increase of PKM2 protein levels. Compared with wild type, PKM2 with the phosphorylation-defective mutation displayed a reduced effect on glycolysis, co-activating HIF-1α and β-catenin, and cell proliferation, while enhancing mitochondrial respiration of cancer cells. These findings demonstrate that PIM2-dependent phosphorylation of PKM2 is critical for regulating the Warburg effect in cancer, highlighting PIM2 as a potential therapeutic target.
35
Gregg L. Semenza, Bing‐Hua Jiang, Sandra W. Leung et al. · Journal of Biological Chemistry · 1996 · 1.8K citations · Full text
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo, Hongxia Hu, Ryan Chang et al. · Cell · 2011 · 1.4K citations · Full text
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang, Yan Xia, Haitao Ji et al. · Nature · 2011 · 1K citations · Full text